Free Trial
→ Bank of America: 'Digital Dollar Inevitable' (From Decentralized Masters) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$294.15
+2.9%		$270.23
$190.75
▼
$298.74
$519.70B0.26.35 million shs8.41 million shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$115.58
+5.6%		$104.09
$81.97
▼
$132.02
$199.99B0.5411.20 million shs12.71 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$88.43
+6.6%		$85.51
$54.11
▼
$92.59
$32.98B1.455.02 million shs4.82 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$482.10
+9.4%		$404.05
$328.57
▼
$603.88
$167.12B1.452.44 million shs4.79 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover
The 7 Best High-Yield Dividend Stocks for 2027

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
-0.96%-0.29%+8.59%+16.22%+34.82%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.76%+6.01%+12.20%+3.55%-11.59%
DexCom, Inc. stock logo
DXCM
DexCom
-2.11%+5.61%-2.80%+0.38%+37.30%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+0.89%-1.15%+12.45%+17.47%-19.01%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$294.15
+2.9%		$270.23
$190.75
▼
$298.74
$519.70B0.26.35 million shs8.41 million shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$115.58
+5.6%		$104.09
$81.97
▼
$132.02
$199.99B0.5411.20 million shs12.71 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$88.43
+6.6%		$85.51
$54.11
▼
$92.59
$32.98B1.455.02 million shs4.82 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$482.10
+9.4%		$404.05
$328.57
▼
$603.88
$167.12B1.452.44 million shs4.79 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover
The 7 Best High-Yield Dividend Stocks for 2027

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
-0.96%-0.29%+8.59%+16.22%+34.82%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.76%+6.01%+12.20%+3.55%-11.59%
DexCom, Inc. stock logo
DXCM
DexCom
-2.11%+5.61%-2.80%+0.38%+37.30%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+0.89%-1.15%+12.45%+17.47%-19.01%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.83
Moderate Buy$297.461.13% Upside
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.89
Moderate Buy$118.322.37% Upside
DexCom, Inc. stock logo
DXCM
DexCom
3.00
Buy$95.507.99% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.80
Moderate Buy$493.542.37% Upside

Current Analyst Ratings Breakdown

Latest ABT, DXCM, ISRG, and ABBV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/4/2026
AbbVie Inc. stock logo
ABBV
AbbVie
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$315.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingMarket Perform$275.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$288.00 ➝ $322.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$300.00 ➝ $340.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetNeutral$275.00 ➝ $295.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Leerink Partners logo
Leerink Partners
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOutperform$309.00 ➝ $342.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$310.00 ➝ $346.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOutperform$280.00 ➝ $330.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$290.00 ➝ $325.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$290.00 ➝ $338.00
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingStrong-Buy$94.00 ➝ $97.00
(Data available from 11/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$61.16B8.50$15.42 per share19.07($1.83) per share-160.74
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B4.51$7.33 per share15.76$30.35 per share3.81
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B7.07$2.89 per share30.61$6.80 per share13.00
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B16.60$10.24 per share47.09$46.50 per share10.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.23B$5.8150.6318.251.3115.67%-435.41%16.89%N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$2.6843.1319.491.939.75%17.97%9.22%N/A
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5534.6828.621.4019.42%37.77%15.98%N/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.2758.3046.403.0125.54%18.17%15.73%N/A

Latest ABT, DXCM, ISRG, and ABBV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/30/2026Q3 2026
AbbVie Inc. stock logo
ABBV
AbbVie
$3.73$3.82+$0.09$2.37$17.32 billion$17.40 billion
10/29/2026Q3 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6750$0.73+$0.0550$0.72$1.33 billion$1.34 billion
10/21/2026Q3 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.42$1.42N/A$0.53$12.99 billion$13.01 billion
10/20/2026Q3 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.65$3.00+$0.35$1.49$2.91 billion$3.05 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.922.35%+6.80%119.10%53 Years
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.18%+10.39%94.03%54 Years
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A

Latest ABT, DXCM, ISRG, and ABBV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/29/2026
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.822.47%1/15/20271/15/20272/16/2027
9/10/2026
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.732.44%10/15/202610/15/202611/16/2026
9/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.4%10/15/202610/15/202611/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
N/A
0.81
0.69
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.38
0.97
DexCom, Inc. stock logo
DXCM
DexCom
0.49
1.74
1.40
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
3.33
2.49

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.06%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
57,0001.77 billion1.77 billionOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000372.95 million371.91 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021346.64 million344.56 millionOptionable

Recent News About These Companies

Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Momentum Stock
November 4 at 10:51 AM  |  zacks.comhttps://www.zacks.com/stock/news/3022997/here-s-why-intuitive-surgical-inc-isrg-is-a-strong-momentum-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_momentum_score-3022997
Intuitive Surgical Stock (ISRG) Still Looks Worth Its Premium
November 4 at 9:30 AM  |  tipranks.comhttps://www.tipranks.com/news/article/intuitive-surgical-stock-isrg-still-looks-worth-its-premium?utm_source=marketbeat.com&utm_medium=referral
Intuitive Surgical, Inc. $ISRG Stock: Rakuten Investment Management Inc. Raises Holdings
November 4 at 6:32 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-stock-rakuten-investment-management-inc-raises-holdings-2026-11-04/
Intuitive Surgical, Inc. $ISRG Shares Purchased by Provenance Wealth Advisors LLC
November 4 at 6:23 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-shares-purchased-by-provenance-wealth-advisors-llc-2026-11-04/
MGO One Seven LLC Sells 11,677 Shares of Intuitive Surgical, Inc. $ISRG
November 4 at 5:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-mgo-one-seven-llc-sells-11677-shares-of-intuitive-surgical-inc-isrg-2026-11-04/
Intuitive Surgical, Inc. $ISRG Shares Acquired by Factory Mutual Insurance Co.
November 4 at 3:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-shares-acquired-by-factory-mutual-insurance-co-2026-11-04/
AIA Group Ltd Sells 8,950 Shares of Intuitive Surgical, Inc. $ISRG
November 4 at 3:03 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-aia-group-ltd-sells-8950-shares-of-intuitive-surgical-inc-isrg-2026-11-04/
Why Intuitive, with 22% Revenue Growth, Is Lowering Forceps Prices—Latest Earnings Analysis
November 3 at 11:00 PM  |  note.comN
Is Intuitive Surgical Stock Worth More Than Its Competitors?
November 3 at 5:59 PM  |  trefis.comT
Intuitive Surgical (ISRG) Drives Better Outcomes and Lower Care Costs
November 3 at 5:59 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/intuitive-surgical-isrg-drives-better-142635109.html
Intuitive Surgical (ISRG) Stock May Be Near Fair Value On Cash Flow
November 3 at 5:59 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-stock-may-161645303.html
Intuitive Surgical, Inc. $ISRG Shares Acquired by Vise Technologies Inc.
November 3 at 5:20 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-shares-acquired-by-vise-technologies-inc-2026-11-03/
Intuitive Surgical, Inc. $ISRG Stock: Greenfield Seitz Capital Management LLC Raises Position
November 3 at 4:07 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-stock-greenfield-seitz-capital-management-llc-raises-position-2026-11-03/
Intuitive Surgical, Inc. $ISRG Stock: BOCHK Asset Management Ltd Boosts Holdings
November 3 at 3:12 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-stock-bochk-asset-management-ltd-boosts-holdings-2026-11-03/
Is This Number The Biggest Risk To Intuitive Surgical Stock?
November 2 at 9:19 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/number-biggest-risk-intuitive-surgical-083508167.html
Intuitive Surgical Appoints Aaron Martin to Board of Directors
November 2 at 5:11 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/intuitive-surgical-appoints-aaron-martin-to-board-of-directors?utm_source=marketbeat.com&utm_medium=referral
Intuitive Appoints Aaron Martin to its Board of Directors
November 2 at 4:15 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/02/3393750/7637/en/intuitive-appoints-aaron-martin-to-its-board-of-directors.html
Intuitive Surgical, Inc. $ISRG Stock Bought by One Way Holdings LLC
November 2 at 8:20 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-stock-bought-by-one-way-holdings-llc-2026-11-02/
Intuitive Surgical, Inc. $ISRG Shares Sold by Traynor Capital Management Inc.
November 2 at 7:56 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-shares-sold-by-traynor-capital-management-inc-2026-11-02/
Intuitive Surgical, Inc. $ISRG Stock Position Lifted by Bank Julius Baer & Co. Ltd Zurich
November 2 at 4:15 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-stock-position-lifted-by-bank-julius-baer-co-ltd-zurich-2026-11-02/
Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
November 1 at 3:51 PM  |  fool.comhttps://www.fool.com/investing/2026/11/01/intuitive-surgical-stock-just-fell-despite-a-22-re/?source=marketbeat&utm_source=marketbeat&utm_medium=feed&utm_campaign=article&referring_guid=ef453ea9-fa44-46d6-8fbd-aff775b6eba4

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Salesforce cloud logo in a futuristic tech setting, highlighting CRM enterprise software and AI platform growth.
Salesforce Fuels AI Engine With $5.66B Braze Buyout
By Jeffrey Neal Johnson | October 21, 2026
White Tesla sports car parked at a launch site with rocket boosters visible against a sunset sky.
Tesla's Roadster Reveal Hints at 2 Much Bigger Moves
By Sam Quirke | October 19, 2026
AbbVie logo over a laboratory scene with vials, a pipette, and a DNA helix illustration.
AbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another Test
By Thomas Hughes | November 2, 2026
Branded box, container, syringe applicator, and sealed packets with a CP logo displayed on a bathroom counter.
Cologuard Is Working—So Why Isn’t Abbott Stock?
By Chris Markoch | October 22, 2026
Intuitive Surgical robotic surgery system in operating room, highlighting medical device growth and healthcare stocks.
Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
By Thomas Hughes | October 22, 2026
AbbVie stock logo

AbbVie NYSE:ABBV

$294.15 +8.15 (+2.85%)
Closing price 03:59 PM Eastern
Extended Trading
$293.12 -1.04 (-0.35%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$115.58 +6.18 (+5.65%)
Closing price 03:59 PM Eastern
Extended Trading
$115.64 +0.07 (+0.06%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

DexCom stock logo

DexCom NASDAQ:DXCM

$88.43 +5.46 (+6.58%)
Closing price 03:59 PM Eastern
Extended Trading
$87.92 -0.51 (-0.58%)
As of 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$482.10 +41.35 (+9.38%)
Closing price 04:00 PM Eastern
Extended Trading
$479.20 -2.90 (-0.60%)
As of 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas